Fusariosis occurring in an ulcerated cutaneous CD8+ T cell lymphoma tumor

Chao-Kai Hsu1, Mark Ming-Long Hsu, Julia Yu-Yun Lee

  • 1Department of Dermatology, National Cheng Kung University Medical Center, Tainan, Taiwan.

Insights

Fusarium mold is a growing threat to immunocompromised patients. This case highlights successful treatment of cutaneous fusariosis in a patient with mycosis fungoides using oral voriconazole.

Area of Science:

  • Mycology
  • Dermatology
  • Infectious Diseases

Background:

  • Fusarium species are increasingly recognized as significant pathogens in immunocompromised individuals.
  • Disseminated fusariosis presents with characteristic skin lesions, often mimicking other dermatological conditions.
  • Antifungal resistance is a concern with Fusarium infections.

Purpose of the Study:

  • To report a rare case of cutaneous fusariosis.
  • To describe the clinical presentation in a patient with mycosis fungoides and cutaneous CD8+ lymphoma.
  • To highlight the successful treatment outcome and diagnostic challenges.

Main Methods:

  • Case report of a patient with a pre-existing skin condition.
  • Clinical diagnosis and subsequent laboratory isolation of Fusarium species.
  • Treatment with oral voriconazole.

Main Results:

  • Successful resolution of cutaneous fusariosis after a 3-month course of oral voriconazole.
  • The infection occurred within an ulcerated lesion of cutaneous CD8+ lymphoma, initially confusing the diagnosis with pyoderma gangrenosum.
  • The patient had a history of hypopigmented mycosis fungoides.

Conclusions:

  • Cutaneous fusariosis can occur in patients with underlying hematologic malignancies and pre-existing skin lesions.
  • Early diagnosis through biopsy and fungal isolation is crucial.
  • Systemic antifungal therapy, such as voriconazole, can be effective.